← Back to Search

Electrosurgical Generator

Conventional Electrosurgical Coagulation (CEC) Systems for Mastectomy (CHEST Trial)

N/A
Waitlist Available
Led By Stacey A Carter, MD
Research Sponsored by SurgiQuest, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up two months from procedure
Awards & highlights

CHEST Trial Summary

This trial will compare the Helixar Electrosurgical Generator to Conventional Electrosurgical Coagulation for cutting and/or coagulating tissue during mastectomy procedures.

Eligible Conditions
  • Mastectomy

CHEST Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~two months from procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and two months from procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The time measured from post-mastectomy to hemostasis for each operated breast.
Secondary outcome measures
drain output
Other outcome measures
infection rate

CHEST Trial Design

2Treatment groups
Active Control
Group I: Conventional Electrosurgical Coagulation (CEC) SystemsActive Control1 Intervention
Standard Bovie electrosugical device without argon gas
Group II: HelixAR Electrosurgical Generator (HEG)Active Control1 Intervention
Argon gas and high frequency electrical current ablation device

Find a Location

Who is running the clinical trial?

SurgiQuest, Inc.Lead Sponsor
5 Previous Clinical Trials
590 Total Patients Enrolled
Stacey A Carter, MDPrincipal InvestigatorBaylor St. Luke's Medical Center
~20 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top